The Marmara University Genetic and Metabolic Diseases Research and Implementation Centre (GEMHAM), was established by Marmara University in May, 2009 with the support of the “Research Substructure Project” from the DPT. The Diretorship was published in the Official Gazette on 27 June, 2010 and the Centre started to operate in association with the Rector’s Office of Marmara University.
The aims and duties of the centre are as below;
To be a cetnre that is geared towards meeting the needs of a well-equipped, wide-ranging Research Centre with a contemporary technological substructure that will work to develop distinguished scientific research.
To carry out experimental studies that are geared towards human health and which always keep ethical values to the fore.
To be a research, development and implementation centre that can carry out research for all of Marmara University’s health units and a centre that is expertised in continuous development.
To follow current scientific developments in genetic and metabolic diseases, to make contributions, create and direct projects on basic and clinical research, to collect data and arrive at conclusions.
The centre provides services to other institutions that are concerned with the subject and the infrastructure.
To train new and young researchers in the centre, to provide post-graduate education and to apply to outside source projects in a wider range and to cooperate with these outside sources
To increase the education, service and research services that are being carried out today within the university and to increase the number of publications.
To present to the researchers a centre that is equipped with the latest technological instruments. To support the researchers who work in the centre, the academic staff and technical personnel, providing guidance in any problems that might arise.
To determine the relationship between the genotypic (variatiosn, polymorphism, mutations, etc) in society and phenotypic types (inclination to disease or sensitivity to biological pathogens, drugs or toxins, etc.).
In order to ensure that the protein structure and functions which provide genetic information about the human genome are brought to light and to understand how they affect one another and to ensure basic comprehension of the pathology of disease: the relative frequency of some hereditary metabolic diseases is greater than the frequency of intermarriage in Turkey. As the symptoms of hereditary metabolic diseases are related to the degree of accumulation of toxic materials, in the first few neo-natal examinations no evidence of illness is detected. The way that clinical symptoms appear, the age at which they appear and the progress of the same are important for diagnosis and successful treatment. Although the symptoms can be identified in early infanthood, if they are identified at a later stage, this can lead to retardation, negatively affect physical development and lead to other problems that will affect the individual throughout life. For these reasons, early diagnosis is very important. The basic aim of the Centre is to identify methods of advanced analysis for genetic and metabolic diseases and analyze metabolic diseases in the neonatal period.
Dr. Yavuz TAGA
Dr. Nesrin KARTAL ÖZER
0216 700 13 73
0216 700 13 74 (fax)
Marmara University, Tıbbiye Avenue. 34668 Haydarpaşa/Istanbul
This page updated by Genetic and Metabolic Diseases Research and Implementation Centre on 07.08.2019 13:02:57